Does anyone here follow Ariad (ARIA)? The stock looks awfully cheap as its drug, deforolimus, partnered with Merck, moves along in its Phase III under a SPA in metastatic sarcomas.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.